Mendoza, Abdel Azis .

HRN: 21-47-01  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2022
AMPICILLIN 250MG (VIAL)
06/16/2022
06/16/2022
IVTT
85mg
Q12
Prematurity
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: